Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (101034261)
Article History
Accepted: 11 October 2024
First Online: 3 January 2025
Declarations
:
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: Clinical trial 2012-004482-40, titled “Evaluation of the clinical utility of a standardized protocol of tapering strategies for patients with rheumatoid arthritis (RA) in persistent clinical remission on biologic therapy: an open-label, randomized, controlled study” by Francisco J. Blanco García.